{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 15,
  "pageCount": 41,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide uses a timeline diagram and a comparison table to challenge AXDX's claimed 75% time advantage.",
  "elementsJson": [
    "timeline_visual",
    "comparison_table",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/15",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-15",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Thus, our estimation using a corrected comparator suggests that the PhenoTest is faster by about 16h to deliver AST results, because it does skip the step of sub-cultures. Therefore, the time advantage is only 40% and not more than 75%, as claimed by AXDX.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a0-afbacfa230e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.243,
        "w": 0.423,
        "x": 0.118,
        "y": 0.181
      },
      "kind": "diagram",
      "text": "Timeline comparison of PhenoTest vs MALDI+BD Phoenix",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fa5645f-af2c-4202-b116-cf5312191463",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Time saving, %: 40%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a0-b37b3d5ac8ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.235,
        "w": 0.764,
        "x": 0.118,
        "y": 0.404
      },
      "kind": "paragraph",
      "text": "Time from the blood sample drawn to culture positivity is 16.2h... Thus, our estimation using a corrected comparator suggests that the PhenoTest is faster by about 16h... the time advantage is only 40% and not more than 75%, as claimed by AXDX.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d71ab53-f4f3-4879-869b-ae90f4126f2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.061,
        "w": 0.764,
        "x": 0.118,
        "y": 0.092
      },
      "kind": "paragraph",
      "text": "We used data from the diagram above to estimate the Pheno system time advantage over MALDI+BD Phoenix. In the Table and Figure below we reproduced complete timelines starting from the clinically relevant time of the blood sample drawn.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6eedae97-0812-4926-b447-273a68a8fb25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.061,
        "w": 0.764,
        "x": 0.118,
        "y": 0.763
      },
      "kind": "paragraph",
      "text": "AXDX is secretive about reagent revenue, because disclosing it would reveal poor Pheno system utilization. A year ago, in the Q218 Earnings call, AXDX said this about its reagent revenue expectations.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d528d7dc-56b7-420a-8129-b924002391c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.243,
        "w": 0.323,
        "x": 0.559,
        "y": 0.181
      },
      "kind": "table",
      "text": "Comparison table of hours for Culture Positivity, ID, AST, and Total time.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6a22aa84-efe2-4349-8185-c89624771080",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.764,
        "x": 0.118,
        "y": 0.688
      },
      "kind": "title",
      "text": "Reagent revenues per system, carefully concealed by management, are below AXDX’s already reduced expectations and trailing down",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78f28969-8fc8-439f-8dda-88af06de4bf6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "c5105861-4f53-4aa6-9ebc-dd1c3e3829a0",
      "evidence": "comparison table of hours for Culture Positivity, ID, AST, and Total time",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "99c68795-dbf4-40b4-8cb2-d9531e0717f0",
      "evidence": "Comparison of PhenoTest vs MALDI+BD Phoenix timelines",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 10,
      "beatId": "fad27230-482c-4ecc-ab6e-29145dc49e07",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document further emphasizes the limitations and drawbacks of the Pheno system, including the structure of Pheno lease agreements and the uncertainty of future reagent revenue.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}